Prescription for Inequality: How Patent Monopolies Turn Lifesaving Drugs Into Instruments of Economic Exclusion
America's pharmaceutical patent system does not merely protect innovation — it manufactures scarcity, rations survival, and extracts maximum profit from the bodies of those least able to resist. From insulin-rationing diabetics in the Midwest to suppressed generic competitors blocked at every regulatory turn, the architecture of drug pricing reveals a caste logic Dr. Ambedkar would have recognized immediately: access to the most basic necessities of life, gatekept by those with the power to set